Recent advances in late‐stage selective deuteration for drug development
Applied Organometallic Chemistry · 2024-10 · 38 (10)
DOI: 10.1002/aoc.7602 ↗At a glance
Journal article in Applied Organometallic Chemistry, 2024-07. Written by Xuan Wang and 5 co-authors. Cited 18 times so far (Crossref); 116 references. Funded by: Foundation for Innovative Research Groups of the National Natural Science Foundation of China, Food and Drug Administration, Nanchang Hangkong University.
Abstract (original language)
Deuteration has emerged as a significant method for investigating kinetic isotope effects in chemical reactions. In recent years, research on deuteration has revealed that this reaction often alters the pharmacokinetic or toxicological properties of drug molecules, thereby enhancing their therapeutic effect. Therefore, deuteration is considered as a potential avenue for drug research direction. Since the approval of the first deuterated drug, “deutetrabenazine,” by the American Food and Drug Administration (FDA) in 2017, deuteration has been applied in the development of a variety of novel drugs. Research on deuteration technology has matured with the publication of numerous deuteration strategies. This article reviews recently reported strategies for late‐stage selective deuteration, discusses the challenges associated with current deuteration strategies, and presents future prospects for the synthesis of deuterated drugs.
Funding
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China
- Food and Drug Administration
- Nanchang Hangkong University
Cite
APA
Wang, X., Luo, Y., Luo, Y., Liu, M., Lu, C., & Song, R. (2024). Recent advances in late‐stage selective deuteration for drug development. Applied Organometallic Chemistry, 38(10). https://doi.org/10.1002/aoc.7602
Vancouver
Wang X, Luo Y, Luo Y, Liu M, Lu C, Song R. Recent advances in late‐stage selective deuteration for drug development. Applied Organometallic Chemistry. 2024;38(10). doi:10.1002/aoc.7602
BibTeX
@article{Wang2024,
author = {Wang, Xuan and Luo, Yu‐Bo and Luo, Yun‐Xia and Liu, Mao‐Chen and Lu, Chang‐Hai and Song, Ren‐Jie},
title = {Recent advances in late‐stage selective deuteration for drug development},
journal = {Applied Organometallic Chemistry},
year = {2024},
volume = {38},
number = {10},
doi = {10.1002/aoc.7602}
}
EUVIMED